Hello guys, Welcome to Africa's Largest Video Search Engine, and you are watching The Rationale for FOLFOX and Bevacizumab in mCRC. and this video is uploaded by Targeted Oncology at 2017-09-06T08:33:31-07:00. We are just promoting this video only for entertainment and educational purpose only. I hop you like our Video Search Engine. [xr2q8P--GOA]
| Name | The Rationale for FOLFOX and Bevacizumab in mCRC |
| Video Uploader | Video From Targeted Oncology |
| Upload Date | This Video Uploaded At 06-09-2017 15:33:31 |
| Video Discription | Wells Messersmith, MD, describes the rationale for using FOLFOX/bevacizumab as a second-line therapy in a patient with metastatic colorectal cancer and the rationale for continuing bevacizumab beyond progression. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/ [xr2q8P--GOA] |
| Category | Education |
| Tags | targeted oncology | oncology | cancer |
